Welcome to 1-Acne-Treatment.Net
Acne Prescription Treatment Article
Acne Treatment Disclaimer
1-acne-treatment.net has used its best efforts in preparing the
acne treatment articles below for your inspection. However,
1-acne-treatment.net make no representation regarding accuracy,
applicability, fitness, or completeness of these acne treatment
articles. The acne treatment material provided is strictly for
educational purposes. Therefore, if you wish to apply ideas
contained in these acne treatment articles, you are taking full
responsibility for your actions.
1-acne-treatment.net shall in no event be held liable to any
party for any direct, indirect, punitive, special, incidental or
other consequential damages arising directly or indirectly from
any use of this acne treatment material, which is provided 'as
is', and without warranties.
Acne Vulgaris and Its Causes
Acne vulgaris, commonly known as acne or pimples, is a common skin disorder that
plagues about 85% to 100% of people at some time during their lives. It affects
people of every age, gender and race, although it is more evident in teenagers.
Acne vulgaris is actually characterized by non-inflammatory follicular papules
or comedones as well as by inflammatory papules, pustules, and nodules in its
more acute forms.
Acne vulgaris occur as it affects the areas of the skin with the densest
population of sebaceous follicles. The common areas affected are the face, neck,
upper part of the chest, and the back, although it may also appear on different
parts of the body like the head and the genital area.
Numerous studies have noted that there are generally four major factors that are
responsible for the development of an acne lesion. The pathogenesis of acne
vulgaris is deemed multifactorial due to this finding. These four factors that
trigger the development of acne vulgaris include the follicular epidermal
hyperproliferation and hyperkeratinization, excess sebum, propionibacterium
acnes, and inflammation.
The follicular epidermal hyperproliferation and hyperkeratinization actually
appears to be one of the main events in the formation and development of acne
vulgaris. The findings have noted that the increasing levels of the adrenally
derived androgen dehydropiandrosterone sulfate (DHEAS) are correlated with the
emergence of the microcomedo, which is actually the primary acne vulgaris
lesion. This development may then aggravate the follicular epidermal
hyperproliferation, which may also be stimulated by an alteration in sebum and
lipid levels in the acne vulgaris lesions.
Excess sebum is the second factor in the formation of acne vulgaris. It plays
its role as the hormonal changes greatly trigger the formation of acne vulgaris.
Then, there is the P. acnes, which is a microaerophilic organism found in many
acne vulgaris lesions. It basically stimulates inflammation by emitting
proinflammatory mediators that disperse through the follicle wall. Some findings
also note that hypersensitivity to P. acnes can explain why many of the people
develop inflammatory acne vulgaris.
Finally, recent studies have shown that inflammation may be a primary or
secondary phenomenon in the development of acne vulgaris. Its secondary
inflammatory response has been shown on its association to P. acnes. However,
the proinflammatory cytokines IL-1a expression has been recognized in the
microcomedone, which may play a large role in the formation of acne vulgaris.
Acne vulgaris, through recent findings, has been found out to cause physical
pain and psychological suffering. It can even lead to scarring which may last
for a lifetime, and certain illness like fever and arthritis may result from it.
Acne Prescription Treatment Best products
Acne Prescription Treatment News
Acne treatment gets US approval
Kiwi company Douglas Pharmaceuticals has won approval to sell its locally developed acne medication in the United States.
Read more...New study could bring relief to acne patients
A breakthrough could be on the way for acne patients, yet experts at the North Carolina Research Campus are enrolling participants in a new study, using genetics to help find safer ways to treat acne. With the help of 250 participants, a M.U.R.D.O.C.K. study conducted by Duke University experts, could lead to new, safer ways to treat severe acne.
Read more...NZ-developed acne drug approved for sale in US by FDA
A NZ developed medication for acne has been approved for sale in America.
Read more...Palomar Medical Reports Financial Results for Fourth Quarter and Fiscal Year 2011
BURLINGTON, Mass. -- Palomar Medical Technologies, Inc. , a leading researcher and developer of light-based systems for cosmetic treatments, today announced financial results for the fourth quarter and ...
Read more...Obagi Medical Products to Report Fourth Quarter and Full Year 2011 Financial Results and Host a Conference Call on ...
Obagi Medical Products, Inc. , a leader in topical aesthetic and therapeutic skin health systems, today announced it will report financial results for its fourth quarter and year ended December 31, 2011 after market close on Thursday, March 8, followed by an investor conference call at 4:30 p.m.
Read more...Galderma Announces Availability of New Metrogel(R) 1% Pump Dispenser for the Treatment of Papulopustular Rosacea
FORT WORTH, TX-- - Galderma Laboratories, L.P. today announced the availability of a new pump dispenser design for MetroGel® Gel, 1%, the most powerful strength of topical metronidazole available in a ...
Read more...